Krazati to NSC lung cancer
Drug Name: Krazati Active Ingredient: adagrasib Indications: To treat KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer in adults who have received at least one prior systemic therapy…
Drug Name: Krazati Active Ingredient: adagrasib Indications: To treat KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer in adults who have received at least one prior systemic therapy…